D. Batisse

发表

Lack of interference between ribavirin and nucleosidic analogues in HIV/HCV co-infected individuals undergoing concomitant antiretroviral and anti-HCV combination therapy.

M. Kazatchkine, C. Piketty, A. Landau, 2000, AIDS.

Clinical recurrences of COVID-19 symptoms after recovery: Viral relapse, reinfection or inflammatory rebound?

N. Benech, B. Pozzetto, F. Lescure, 2020, Journal of Infection.

Comparison of liver fibrosis blood tests developed for HCV with new specific tests in HIV/HCV co-infection.

F. Carrat, C. Michelet, D. Guyader, 2010, Journal of hepatology.

Sexually transmitted acute infection with a clustered genotype 4 hepatitis C virus in HIV-1-infected men and inefficacy of early antiviral therapy

C. Rouzioux, S. Pol, H. Fontaine, 2006, AIDS.

Acute hepatitis C infection in HIV positive men who have sex with men in Paris, France, 2001-2004.

J. Desenclos, S. Pol, L. Gambotti, 2005, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Real-World Efficacy of Daclatasvir and Sofosbuvir, With and Without Ribavirin, in HIV/HCV Coinfected Patients With Advanced Liver Disease in a French Early Access Cohort

V. de Lédinghen, F. Dabis, T. Allègre, 2017, Journal of acquired immune deficiency syndromes.

HIV Infection and Long‐Term Residual Cardiovascular Risk After Acute Coronary Syndrome

G. Finet, F. Duclos, J. Trochu, 2020, Journal of the American Heart Association.

Pseudomonas aeruginosa infection in human immunodeficiency virus infected patients.

M. Guiguet, J. Meynard, F. Barbut, 1999, The Journal of infection.

HIV infection and COVID-19: risk factors for severe disease

L. Slama, D. Salmon, L. Weiss, 2020, AIDS.

Clinical, virological and imaging profile in patients with prolonged forms of COVID-19: A cross-sectional study

E. Sorbets, F. Canouï-Poitrine, D. Salmon-Céron, 2020, Journal of Infection.

Sustained exacerbation of cryoglobulinaemia-related vasculitis following treatment of hepatitis C with peginterferon alfa.

M. Kazatchkine, L. Weiss, M. Karmochkine, 2004, European journal of gastroenterology & hepatology.

A highly virulent variant of HIV-1 circulating in the Netherlands

Michael J. Rausch, H. Jessen, A. Trkola, 2022, Science.

Intramedullary abscess resulting from disseminated cryptococcosis despite immune restoration in a patient with AIDS.

M. Kazatchkine, J. Mikol, J. Thiebaut, 2002, The Journal of infection.

Acute retinal necrosis in the course of AIDS: study of 26 cases

M. Baudrimont, G. Pialoux, B. Dupont, 1996, AIDS.

Efficacy and safety of combination therapy with interferon-α2b and ribavirin for chronic hepatitis C in HIV-infected patients

M. Kazatchkine, L. Bélec, J. Duong van Huyen, 2000 .

Efficacy and safety of combination therapy with interferon-a2b and ribavirin for chronic hepatitis C in HIV-infected patients

M. Kazatchkine, A. Landau, D. Batisse, 2000 .

Toxic effects of nucleoside reverse transcriptase inhibitors on the liver. Value of electron microscopy analysis for the diagnosis of mitochondrial cytopathy.

M. Kazatchkine, P. Bruneval, M. Bélair, 2003, American journal of clinical pathology.

Discrepant responses to triple combination antiretroviral therapy in advanced HIV disease

M. Kazatchkine, L. Bélec, J. Gilquin, 1998, AIDS.

Efficacy and safety of combination therapy with interferon-α2b and ribavirin for chronic hepatitis C in HIV-infected patients

M. Kazatchkine, L. Bélec, G. Pialoux, 2000 .

Long-term efficacy of combination therapy with interferon-α2b and ribavirin for severe chronic hepatitis C in HIV-infected patients

M. Kazatchkine, P. Bruneval, L. Bélec, 2001 .

High frequency of integrase Q148R minority variants in HIV-infected patients naive of integrase inhibitors

C. Charpentier, P. Tisserand, L. Weiss, 2010, AIDS.

Alteration of cytochrome oxidase subunit I labeling is associated with severe mitochondriopathy in NRTI-related hepatotoxicity in HIV patients

M. Kazatchkine, D. Heudes, P. Bruneval, 2006, Modern Pathology.

[Mediastinitis after sternotomy. Mortality and hospital length of stay. Groupe parisien détude des sternotomies].

J. Lucet, G. Brücker, D. Batisse, 1997, Archives des maladies du coeur et des vaisseaux.

Telaprevir for HIV/hepatitis C virus-coinfected patients failing treatment with pegylated interferon/ribavirin (ANRS HC26 TelapreVIH): an open-label, single-arm, phase 2 trial.

D. Neau, P. Morlat, C. Michelet, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Long-term efficacy of combination therapy with interferon-alpha 2b and ribavirin for severe chronic hepatitis C in HIV-infected patients.

M. Kazatchkine, P. Bruneval, L. Bélec, 2001, AIDS.

Effect of interferon and ribavirin on HIV viral load.

M. Kazatchkine, C. Piketty, A. Landau, 2000, AIDS.

Severe liver mitochondriopathy with normal liver histology and normal lactate levels in patients receiving nucleoside analogues.

M. Kazatchkine, P. Bruneval, J. Duong van Huyen, 2002, AIDS.

Raltegravir-based regimens are effective in HIV-1 group O-infected patients.

J. Plantier, V. Daneluzzi, D. Batisse, 2012, Journal of acquired immune deficiency syndromes.

Efficacy, safety and patient‐reported outcomes of ledipasvir/sofosbuvir in NS3/4A protease inhibitor‐experienced individuals with hepatitis C virus genotype 1 and HIV coinfection with and without cirrhosis (ANRS HC31 SOFTRIH study)

V. de Lédinghen, Y. Yazdanpanah, D. Neau, 2018, HIV medicine.

Efficacy and safety of combination therapy with interferon-alpha2b and ribavirin for chronic hepatitis C in HIV-infected patients.

M. Kazatchkine, L. Bélec, J. Duong van Huyen, 2000, AIDS.

Prevalence of and factors associated with depression among people living with HIV in France

F. Marion, M. Duracinsky, F. Lert, 2017, HIV medicine.